Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia)

NCT04268472 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: GP30101
DRUG: Prezista®
DRUG: GP30101
DRUG: Prezista®

Sponsor

Geropharm